FDA Approves High-Concentration, Citrate-Free Cyltezo for the Treatment of Chronic Inflammatory Diseases
This citrate-free and high-dose approval of the biosimilar Humira provides another option to treat patients who are living with various inflammatory diseases.
United States Steven Taylor Stephen Pagnotta Biosimilar Adalimumab Adbm Boehringer Ingelheim Crohn Colitis Foundation
Source: pharmacytimes.com